These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9714333)

  • 1. Use of a medium-term liver focus bioassay to assess the hepatocarcinogenicity of 1,2,4,5-tetrachlorobenzene and 1,4-dichlorobenzene.
    Gustafson DL; Coulson AL; Feng L; Pott WA; Thomas RS; Chubb LS; Saghir SA; Benjamin SA; Yang RS
    Cancer Lett; 1998 Jul; 129(1):39-44. PubMed ID: 9714333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative hepatocarcinogenicity of hexachlorobenzene, pentachlorobenzene, 1,2,4,5-tetrachlorobenzene, and 1,4-dichlorobenzene: application of a medium-term liver focus bioassay and molecular and cellular indices.
    Gustafson DL; Long ME; Thomas RS; Benjamin SA; Yang RS
    Toxicol Sci; 2000 Feb; 53(2):245-52. PubMed ID: 10696772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium-term bioassay for the hepatocarcinogenicity of hexachlorobenzene.
    Cabral R; Hoshiya T; Hakoi K; Hasegawa R; Ito N
    Cancer Lett; 1996 Feb; 100(1-2):223-6. PubMed ID: 8620445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stochastic simulation of hepatic preneoplastic foci development for four chlorobenzene congeners in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Gustafson DL; Long ME; Dobrev ID; Chubb LS; Xu Y; Lapidot SA; Andersen ME; Yang RS
    Toxicol Sci; 2003 Jun; 73(2):301-14. PubMed ID: 12700395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for hepatocarcinogenic activity of pentachlorobenzene with intralobular variation in foci incidence.
    Thomas RS; Gustafson DL; Pott WA; Long ME; Benjamin SA; Yang RS
    Carcinogenesis; 1998 Oct; 19(10):1855-62. PubMed ID: 9806169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A physiologically based pharmacodynamic analysis of hepatic foci within a medium-term liver bioassay using pentachlorobenzene as a promoter and diethylnitrosamine as an initiator.
    Thomas RS; Conolly RB; Gustafson DL; Long ME; Benjamin SA; Yang RS
    Toxicol Appl Pharmacol; 2000 Jul; 166(2):128-37. PubMed ID: 10896854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of carcinogenicity of daminozide, alone or in combination with its contaminant 1,1-dimethylhydrazine, in a medium-term bioassay.
    Cabral R; Hakoi K; Hoshiya T; Hasegawa R; Ito N
    Teratog Carcinog Mutagen; 1995-1996; 15(6):307-12. PubMed ID: 8732881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of potential of low dose N-nitrosodimethylamine to induce preneoplastic lesions, glutathione S-transferase placental form-positive foci, in rat liver.
    Fukushima S; Wanibuchi H; Morimura K; Nakae D; Tsuda H; Imaida K; Shirai T; Tatematsu M; Tsukamoto T; Hirose M; Furukawa F
    Cancer Lett; 2005 May; 222(1):11-5. PubMed ID: 15837536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of carcinogens on the induction of placental glutathione S-transferase-positive liver nodules in a short-term assay and of hepatocellular carcinomas in a long-term assay.
    Ogiso T; Tatematsu M; Tamano S; Tsuda H; Ito N
    Toxicol Pathol; 1985; 13(4):257-65. PubMed ID: 3834582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of initiation activity in rat liver of low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
    Fukushima S; Wanibuchi H; Morimura K; Wei M; Nakae D; Konishi Y; Tsuda H; Takasuka N; Imaida K; Shirai T; Tatematsu M; Tsukamoto T; Hirose M; Furukawa F
    Cancer Lett; 2003 Feb; 191(1):35-40. PubMed ID: 12609707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of in vivo genotoxicity and liver initiation activity of dicyclanil.
    Moto M; Sasaki YF; Okamura M; Fujita M; Kashida Y; Machida N; Mitsumori K
    J Toxicol Sci; 2003 Aug; 28(3):173-9. PubMed ID: 12974609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoting potential of a Jamaica quassia extract in a rat medium-term hepatocarcinogenesis bioassay.
    Woo GH; Shibutani M; Inoue K; Fujimoto H; Takahashi M; Lee KY; Hirose M
    Food Chem Toxicol; 2007 Jul; 45(7):1160-4. PubMed ID: 17306917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the hepatic and renal effects of 1,4-dichlorobenzene in the rat and mouse.
    Lake BG; Cunninghame ME; Price RJ
    Fundam Appl Toxicol; 1997 Sep; 39(1):67-75. PubMed ID: 9325029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of liver glutathione S-transferase placental form-positive foci development in the rat hepatocarcinogenesis by Porphyra tenera (Asakusa-nori).
    Ichihara T; Wanibuchi H; Taniyama T; Okai Y; Yano Y; Otani S; Imaoka S; Funae Y; Fukushima S
    Cancer Lett; 1999 Jul; 141(1-2):211-8. PubMed ID: 10454264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocarcinogenesis in female Sprague-Dawley rats following discontinuous treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Walker NJ; Tritscher AM; Sills RC; Lucier GW; Portier CJ
    Toxicol Sci; 2000 Apr; 54(2):330-7. PubMed ID: 10774815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medium-term bioassay system for detection of carcinogens and modifiers of hepatocarcinogenesis utilizing the GST-P positive liver cell focus as an endpoint marker.
    Ito N; Tatematsu M; Hasegawa R; Tsuda H
    Toxicol Pathol; 1989; 17(4 Pt 1):630-41. PubMed ID: 2629099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Existence of no-observed effect levels for 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline on hepatic preneoplastic lesion development in BN rats.
    Wei M; Hori TA; Ichihara T; Wanibuchi H; Morimura K; Kang JS; Puatanachokchai R; Fukushima S
    Cancer Lett; 2006 Jan; 231(2):304-8. PubMed ID: 16399231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifying effects of various chemicals on preneoplastic and neoplastic lesion development in a wide-spectrum organ carcinogenesis model using F344 rats.
    Fukushima S; Hagiwara A; Hirose M; Yamaguchi S; Tiwawech D; Ito N
    Jpn J Cancer Res; 1991 Jun; 82(6):642-9. PubMed ID: 1906850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium-term bioassays for carcinogenicity of chemical mixtures.
    Ito N; Imaida K; Hirose M; Shirai T
    Environ Health Perspect; 1998 Dec; 106 Suppl 6(Suppl 6):1331-6. PubMed ID: 9860889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.